Top Suppliers:I want be here

108736-35-2

108736-35-2 structure
108736-35-2 structure
  • Name: Lanreotide acetate salt
  • Chemical Name: Lanreotide
  • CAS Number: 108736-35-2
  • Molecular Formula: C54H69N11O10S2
  • Molecular Weight: 1096.323
  • Catalog: Research Areas Cancer
  • Create Date: 2018-08-22 10:15:18
  • Modify Date: 2026-07-02 13:49:12
  • Lanreotide (BIM 23014) is a somatostatin analogue with antineoplastic activity. Lanreotide can be used for the research of carcinoid syndrome[1][2].

Name Lanreotide
Synonyms B-NAPHTHYL-D-ALA-CYS-TYR-D-TRP*LYS-VAL-C YS-THR AMID
Lanreotide Acetate(net)
(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-cboxamide
L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic disulfide, TFA salt
10-(4-Aminobutyl)-N-(1-amino-3-hydroxy-1-oxo-2-butanyl)-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-isopropyl-19-{[3-(2-naphthyl)alanyl]amino}-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE
T4 40mcg, 100 tablets
Lanreotide //BP
3-(2-Naphtyl)-D-Ala-L-Cys-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys-L-Thr-NH2
*Tributyl Acetylcitrate Impurity 7
β-(2-naphthyl)-d-ala-cys-tyr-d-trp-lys-val-cys-thr amide [disulfide bridge: ]
(D-2-NAL5,CYS6,11,TYR7,D-TRP8,VAL10)-SOMATOSTATIN AMIDE
DC-13-116, Angioptin, (D-2-Nal5,Cys6'11,Tyr7,D-Trp8,Val10)-SoMatostatin aMide, BIM-23014, (D-2-Nal5,Cys6·11,Tyr7,D-Trp8,Val10)-SoMatostatin aMide
AUTOGEL
ANGIOPEPTIN
LANREOTIDE
Lanreotide, Somatostatin rector analog
B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am
TIANFUCHEM--108-2--Lanreotide
bim-23014c
Somatuline
LanreotideAcetate impurity
DC-13-116
Lanreotide, Angioptin
10-(4-Aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-isopropyl-19-{[3-(2-naphthyl)alanyl]amino}-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
ANGIOPTIN
H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2
H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2, (DISULFIDE BOND)
LoMustine
L-Threoninamide,3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-,cyclic (2®
3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic -disulfide
BIM-23014
Lanreotide D8Q: What is Lanreotide D8 Q: What is the CAS Number of Lanreotide D8 Q: What is the storage condition of Lanreotide D8 Q: What e the applications of Lanreotide D8
Lanreotide Ditrifluoroacetate
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-cboxamide
IPSTYL
D-βNal-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys-L-Thr-NH2
Lanreotide Angioptin acetate
D8-Lanreotide
Description Lanreotide (BIM 23014) is a somatostatin analogue with antineoplastic activity. Lanreotide can be used for the research of carcinoid syndrome[1][2].
Related Catalog
In Vitro Lanreotide (BIM 23014) (100  nM; 24-48 h) combines with radiation increasing in apoptotic sub-G1 proportion[1]. Lanreotide results in a dose-dependent decrease in GH3 cell colony forming units. Lanreotide at concentrations of 1, 10, 100, and 1000  nM results in cell survival rates of 75, 56, 39 and 27% respectively. The IC50 is 57  nM[1]. Lanreotide inhibits GH-secreting pituitary adenoma cell proliferation and hormone release in vitro[2].
In Vivo Lanreotide (2.5-10mg/kg; s.c.; daily for 5 days) results in tumor growth inhibition[1]. Animal Model: Male nude mice, 8 weeks old and 20–25 g in body weight (GH3 tumor-bearing nude mice)[1] Dosage: 2.5, 5, 10 mg/kg Administration: Subcutaneous; daily for 5 days Result: Produced tumor growth inhibition.
References

[1]. Ning S, et al. Lanreotide promotes apoptosis and is not radioprotective in GH3 cells.Endocr Relat Cancer. 2009 Sep;16(3):1045-55.

[2]. Florio T, et al. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.Clin Endocrinol (Oxf). 2003 Jul;59(1):115-28.

Density 1.4±0.1 g/cm3
Boiling Point 1508.2±65.0 °C at 760 mmHg
Molecular Formula C54H69N11O10S2
Molecular Weight 1096.323
Flash Point 865.9±34.3 °C
Exact Mass 1095.467041
PSA 405.68000
LogP 2.89
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.689
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.